U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07157722) titled 'Evaluating the Effect of N-Acetyl Cysteine and Alpha Lipoic Acid in Patients With Beta Thalassemia' on Aug. 28.
Brief Summary: The current study is to investigate the potential roles of N-acetyl cysteine and Alpha-lipoic acid in patients with beta-thalassemia.
Study Start Date: Aug. 30
Study Type: INTERVENTIONAL
Condition:
Beta Thalassemia
Intervention:
DRUG: Iron chelating intervention
JADENU is indicated for the treatment of chronic iron overload due to blood transfusions.
DRUG: N Acetyl cysteine 600mg
N-acetyl cysteine (NAC) 600 mg will be administered orally once daily for 12 weeks.
DRUG: Alpha Lipoic Acid 600 MG Oral ...